Etiopathogenesis of acute hepatic failure: Eastern versus Western countries

Journal of Gastroenterology and Hepatology (Australia)

Volumn 17, Issue SUPPL. 3, 2002, Pages

  Acharya, S K ^a   Batra, Y ^a   Hazari, S ^a   Choudhury, V ^a   Panda, S K ^a   Dattagupta, S ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAMINOPHEN PLUS ISONIAZID; ALPHA INTERFERON; AMIODARONE; AMOXICILLIN PLUS CLAVULANIC ACID; BROMFENAC; CARBAMAZEPINE; COTRIMOXAZOLE; DAPSONE; ETOPOSIDE; FLUTAMIDE; HALOTHANE; IMIPRAMINE; ISONIAZID DERIVATIVE; ISONIAZID PLUS RIFAMPICIN; KETOCONAZOLE; LABETALOL; LISINOPRIL; NICOTINIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; OFLOXACIN; ORGANOPHOSPHORUS COMPOUND; PARACETAMOL; PHENYTOIN; RIFAMPIN PLUS ISONIAZID; SULFONAMIDE; THIOURACIL DERIVATIVE; TOLCAPONE; TROGLITAZONE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALPROIC ACID;

CONFERENCE PAPER; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG OVERDOSE; ENDEMIC DISEASE; GEOGRAPHIC DISTRIBUTION; HEPATITIS A; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HEPATITIS E VIRUS; HUMAN; LIVER FAILURE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SPECIES DIFFERENCE; SUPERINFECTION;

EID: 0036458570     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.17.s3.12.x     Document Type: Conference Paper

References (64)

1. Acharya SK, Dasarathy S, Kumer TL et al. Fulminant hepatitis in a tropical population: Clinical course, cause, and early predictors of outcome. Hepatology 1996; 23: 1448-55.
2. Takahashi Y, Shimuzu M. Aetiology and prognosis of fulminant viral hepatitis in Japan: A multicentric study. J. Gastroenterol. Hepatol. 1991; 6: 159-64.
3. Bernau J, Rueff B, Benhamaou JP. Fulminant and subfulminant liver failure: Definition and causes. Semin. Liver Dis. 1986; 6: 97-106.
4. Williams R, Wendon J. Clinical syndrome and aetiology of fulminant hepatic failure. In: Williams R, Hughes RD, eds. Acute Liver Failure: Improved Understanding and Better Therapy. Proceedings of the 11th BSG/SK and F International Workshop 1990. Herts, UK: SK & F Publication, 1991; 1-5.
5. Lee WM, Sorrel MF. Developing a world view towards acute liver failure. Hepatology 1996; 24: 270-1.
6. Trey C, Davidson C. The management of fulminant hepatic failure. In: Popper H, Schaffner F, eds. Progress in Liver Disease, Vol. 3. New York: Grune & Stratton, 1970; 282-98.
7. O'Grady JG, Schalm SW, Williams R. Acute liver failure: Redefining the syndromes. Lancet 1993; 342: 273-5.
8. Muto Y. Present status of fulminant hepatitis in Japan (1989-91). Gastroenterol. Jpn. 1993; 28 (Suppl. 4): 120-7.
9. Pelman RR, Gavaler JS, Vathiel DH et al. Orthotopic liver transplantation for acute and subacute hepatic failure in adults. Hepatology 1997; 7: 484-9.
10. O'Grady JG, Gimson AES, Thick M et al. Outcome of orthotopic liver transplantation in etiological and clinical variants of acute liver failure. Quart. J. Med. 1988; 69: 817.
11. Tandon BN, Joshi YK, Acharya SK. Subacute hepatic failure. Natl. Med. J. India 1988; 1: 124-6.
12. Tabdon BN, Joshi YK, Krishnamurty L, Tandon HD. Subacute hepatic failure: Is it a distinct entity? J. Clin. Gastroenterol. 1982; 4: 343-6.
13. Gimson AE, O'Grady J, Ede RJ, Portmann B, William R. Late onset hepatic failure: Clinical, serological and histological features. Hepatology 1986; 6: 288-94.
14. Boyer JL, Klatskin G. Patterns of necrosis in acute viral hepatitis. Prognostic value of bridging (subacute hepatic necrosis). N. Engl. J. Med. 1970; 283: 1063-71.
15. Peter RL, Omata M, Aschavai M et al. Protracted viral hepatitis with impaired regeneration. In: Vyas GN, Cohen SN, Schmid., eds. Viral Hepatitis Philadelphia: Franklin Institute Press, 1978, 79-84.
16. Tandon BN, Bernauau J, O'Grady J et al. Recommendations of the International Association for the study of the liver subcommittee on nomenclature of acute and subacute liver failure. J. Gastroenterol. Hepatol. 1999; 14: 403-4.
17. Acharya SK, Panda SK, Saxena A, Dattagupta S. Acute hepatic failure in India: A prospective from the East. J. Gastroenterol. Hepatol. 2000; 15: 473-9.
18. Dhiman RK, Seth AK, Jain S, Chawla YK, Dilwari JB. Prognostic evaluation of early indicators in fulminant hepatic failure by multivariate analysis. Dig. Dis. Sci. 1998; 43: 1311-6.
19. Srivastava KL, Mittal A, Kumar A et al. Predictors of outcome in fulminant hepatic failure in children. Indian J. Gastroenterol. 1998; 17: 43-5.
20. Jaiswal SB, Chitnis DS, Asolkar MV, Naik G, Artwani KK. Aetiology and prognostic factors in hepatic failure in central India. Trop. Gastroenterol. 1996; 17: 217-20.
21. Tandon BN, Joshi YK, Tandon M. Acute liver failure: Experience with 145 cases. J. Clin. Gastroenterol. 1986; 8: 664-8.
22. Khuroo MS. Acute liver failure in India. Hepatology 1997; 26: 244-6.
23. Tandon BN, Acharya SK, Tandon A. Eipdemiology of hepatitis B virus infection in India. Gut 1996; 38 (Suppl. 2): 856-9.
24. Panigrahi AK, Panda SK, Dixit RK et al. Magnitude of hepatitis C virus infection in India: Prevalence in healthy blood donors, acute and chronic liver disease. J. Med. Virol. 1997; 51: 167-74.
25. Ostapowicz G, Lee WM. Acute hepatic failure: A western perspective. J. Gastroenterol. Hepatol. 2000; 15: 480-8.
26. Schiodt FV, Atillasoy E, Shakil AO et al. Etiology and outcome for 295 patients with acute liver failure in the United States. Liver Transpl. Surg. 1999; 5: 29-34.
27. Isai H, Sheil AG, McCaughan GW et al. Fulminant hepatic failure and liver transplantation. Transplant. Proc. 1992; 24: 1475-6.
28. Andreu V, Mas A, Bruguera M et al. Ecstasy: A common cause of severe acute hepatotoxicity. J. Hepatol. 1998; 29: 394-7.
29. Brauer RB, Heidecke CD, Nathrath W et al. Liver transplantation for the treatment of fulminant hepatic failure induced by the ingestion of ecstasy. Transpl. Int. 1997; 10: 229-33.
30. Kanel GC, Cassidy W, Shuster L, Reynolds TB. Cocaine-induced liver cell injury: Comparison of morphological features in man and in experimental models. Hepatology 1990; 11: 646-51.
31. Larrey D, Pageaux GP. Hepatoxicity of herbal remedies and mushrooms. Semin. Liver Dis. 1995; 15: 183-8.
32. Klein AS, Hart J, Brems JJ, Goldstein L, Lewin K, Busuttil RW. Amanita poisoning: Treatment and the role of liver transplantation. Am. J. Med. 1989; 86: 187-93.
33. Woodle ES, Moody RR, Cox KL, Cannon RA, Ward RE. Orthotopic liver transplantation in a patient with Amanita poisoning. JAMA 1985; 253: 69-70.
34. Jochimsen EM, Carmichael WW, An JS et al. Liver failure and death after exposure to microcystins at a hemodialysis center in Brazil. N. Engl. J. Med. 1998; 338: 873-8.
35. Mahler H, Pasi A, Kramer JM et al. Fulminant liver failure in association with the emetic toxin of Bacillus cereus. N. Engl. J. Med. 1997; 336: 1142-8.
36. Sheil AG, McCaughan GW, Thompson JF, Dorney SF, Stephen MS, Bookallil MJ. The first five years' clinical experience of the Australian National Liver Transplantation Unit. Med. J. Aust. 1992; 156: 9-16.
37. Tibbs C, Williams R. Viral causes and management of acute liver failure. J. Hepatol. 1995; 22 (Suppl.): 68-73.
38. Govindarajan S, Chin KP, Redeker AG, Peters RL. Fulminant B viral hepatitis: Role of delta agent. Gastroenterology 1984; 86: 1417-20.
39. Smedile A, Farci P, Verme G et al. Influence of delta infection on severity of hepatitis B. Lancet 1982; 2: 945-7.
40. Lee WM. Acute liver failure. N. Engl. J. Med. 1993; 329: 1862-72.
41. Alter MJ, Mast EE. The epidemiology of viral hepatitis in the United States. Gastroenterol. Clin. North Am. 1994; 23: 437-55.
42. Willner IR, Uhl MD, Howard SC, Williams EQ, Riely CA, Waters B. Serious hepatitis A. An analysis of patients hospitalised during and urban epidemic in the United States. Ann. Intern. Med. 1998; 128: 111-14.
43. Vento S, Garofano T, Renzini C et al. Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C. N. Engl. J. Med. 1998; 338: 286-90.
44. Batra Y, Saraya A, Hazari S et al. Vaccination against hepatitis 'A' virus is not required for north Indian school children: Result of a seroepidemioogical study. WHO Bull. 2002; in press.
45. Acharya SK, Batra Y, Saraya A et al. Vaccination against HAV is not required for Indian patients with chronic liver disease. Natl. Med. J. India 2002; 15: in press.
46. Yoshiba M, Dehara K, Inoue K, Okamoto H, Mayumi M. Contribution of hepatitis C virus to non-A, non-B fulminant hepatitis in Japan. Hepatology 1994; 19: 829-35.
47. Chu CM, Sheen IS, Liaw YF. The role of hepatitis C virus in fulminant viral hepatitis in an area with endemic hepatitis A and B. Gastroenterology 1994; 107: 189-95.
48. Feray C, Gigou M, Samuel D et al. Hepatitis C virus RNA and hepatitis B virus DNA in serum and liver of patients with fulminant hepatitis. Gastroenterology 1993; 104: 549-55.
49. Vento S, Cainelli F, Mirandola F et al. Fulminant hepatitis on withdrawal of chemotherapy in carriers of hepatitis C virus. Lancet 1996; 347: 92-3.
50. Suzuki C, Yamashita S, Korenaga M et al. Detection of hepatitis B virus DNA in liver by polymerase chain reaction for the diagnosis of fulminant hepatitis B. Hepatol. Res. 1998; 12: 23-30.
51. Fukai K, Yokosuka O, Fujiwara K et al. Etiologic considerations of fulminant non-A, non-B viral hepatitis in Japan: Analyses by nucleic acid amplification method. J. Infect. Dis. 1998; 178: 325-33.
52. Inokuchi K, Nakata K, Hamasaki K et al. Prevalence of hepatitis B or C virus infection in patients with fulminant viral hepatitis. An analysis using polymerase chain reaction. J. Hepatol. 1996; 24: 258-64.
53. Mason A, Sallie R, Perrillo R et al. Prevalence of herpes-viridae and hepatitis B virus DNA in the liver of patients with non-A, non-B fulminant hepatic failure. Hepatology 1996; 24: 1361-5.
54. Wright TL, Mamish D, Combs C et al. Hepatitis B virus and apparent fulminant non-A, non-B hepatitis. Lancet 1992; 339: 952-5.
55. Hytiroglou P, Dash S, Haruna Y et al. Detection of hepatitis B and hepatitis C viral sequences in fulminant hepatic failure of unknown etiology. Am. J. Clin. Pathol. 1995; 104: 588-93.
56. Sallie R, Rayner A, Naoumov N, Portmann B, Williams R. Occult HBV in NANB fulminant hepatitis. Lancet 1993; 341: 123.
57. Mutimer D, Shaw J, Neuberger J et al. Failure to incriminate hepatitis B, hepatitis C, and hepatitis E viruses in the aetiology of fulminant non-A non-B hepatitis. Gut 1995; 36: 433-6.
58. Fagan EA, Harrison TJ. Exclusion in liver by polymerase chain reaction of hepatitis B and hepatitis C viruses in acute liver failure attributed to sporadic non-A, non-B hepatitis. J. Hepatol. 1994; 21: 587-91.
59. Feray C, Gigou M, Samuel D et al. Hepatitis C virus RNA and hepatitis B virus DNA in serum and liver of patients with fulminant hepatitis. Gastroenterology 1993; 104: 545-55.
60. Laskus T, Rakela J, Wiesner RH, Steers JL, Persing DH. Lack of evidence for hepatitis B virus (HBV) infection in fulminant non-A, non-B hepatitis. Dig. Dis. Sci. 1994; 39: 1677-82.
61. Teo EKG, Ostrapowicz Hussain M, Lee WM, Fontana RJ, Lok ASF. Hepatitis B infection in patients with acute liver failure in the United States. Hepatology 2001; 33: 972-6.
62. Chaudhuri V, Hazari S, Acharya SK, Panda SK. Cryptic hepatitis B virus infection. Analysis of the complete genomic sequence of HBV from five patients with seronegative viral hepatitis. Hepatology 2001; 34: 326-615.
63. Arora NK, Nanda SK, Gulati S et al. Acute viral hepatic types E, A and B singly and in combination in acute liver failure in children in north India. J. Med. Virol. 1996; 48: 215-21.
64. Acharya SK, Singal DK, Panda SK, Dattagupta S, Dasarathy S. Acute viral hepatitis due to mixed infections may be at high risk to develop subacute hepatic failure. J. Gastroenterol. Hepatol. 2001; 16 (Suppl.): A51.